Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022
Go back to Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 7.93 +0.08 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.85 | 52 Week High | $44.38 | |||
| Open | $7.80 | 52 Week Low | $24.47 | |||
| Day High | $7.99 | P/E | 396.50 | |||
| Day Low | $7.80 | EPS | $0.02 | |||
| Volume | 226,365 | |||||

